Hydroxychloroquine-Chloroquine, QT-Prolongation, and Major Adverse Cardiac Events: A Meta-analysis and Scoping Review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hydroxychloroquine-Chloroquine, QT-Prolongation, and Major Adverse Cardiac Events: A Meta-analysis and Scoping Review
Authors
Keywords
-
Journal
ANNALS OF PHARMACOTHERAPY
Volume -, Issue -, Pages -
Publisher
SAGE Publications
Online
2023-10-26
DOI
10.1177/10600280231204969
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis
- (2022) Andres Cordova Sanchez et al. CARDIOVASCULAR DRUGS AND THERAPY
- The effects of hydroxychloroquine on insulin sensitivity, insulin clearance and inflammation in insulin‐resistant adults: A randomized trial
- (2021) Frederico G. S. Toledo et al. DIABETES OBESITY & METABOLISM
- Hydroxychloroquine in mild-to-moderate COVID-19: a placebo-controlled double blind trial
- (2021) Vincent Dubée et al. CLINICAL MICROBIOLOGY AND INFECTION
- Hydroxychloroquine reduces interleukin-6 levels after myocardial infarction: The randomized, double-blind, placebo-controlled OXI pilot trial
- (2021) Lotta Ulander et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients
- (2021) Álvaro Réa-Neto et al. Scientific Reports
- Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19
- (2021) Gilmar Reis et al. JAMA Network Open
- Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemic
- (2021) Hans H. Liu et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials
- (2021) Augusto Di Castelnuovo et al. Pathogens and Global Health
- Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study—a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
- (2021) Claudia Kedor et al. RMD Open
- Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis
- (2021) Jiawen Deng et al. Future Virology
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
- (2020) Eva Schrezenmeier et al. Nature Reviews Rheumatology
- Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
- (2020) Jinoos Yazdany et al. ANNALS OF INTERNAL MEDICINE
- Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
- (2020) Zahra Sahraei et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
- (2020) Wei Tang et al. BMJ-British Medical Journal
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial
- (2020) Oriol Mitjà et al. CLINICAL INFECTIOUS DISEASES
- Chloroquine against malaria, cancers and viral diseases
- (2020) Wenmin Zhou et al. DRUG DISCOVERY TODAY
- Treating Covid-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind, Randomized Controlled Trial in Hospitalized Patients
- (2020) Robert J Ulrich et al. Open Forum Infectious Diseases
- Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19
- (2020) Wesley H. Self et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients
- (2019) Angel Arnaout et al. BREAST CANCER RESEARCH AND TREATMENT
- Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis
- (2018) Sarah R. Kingsbury et al. ANNALS OF INTERNAL MEDICINE
- Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients
- (2018) Samya Mohammad et al. ARTHRITIS CARE & RESEARCH
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
- (2018) Andrea C. Tricco et al. ANNALS OF INTERNAL MEDICINE
- The GRADE Working Group clarifies the construct of certainty of evidence
- (2017) Monica Hultcrantz et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Efficacy of hydroxychloroquine in hand osteoarthritis: a randomized, double blind, placebo-controlled trial
- (2017) Weiching Lee et al. ARTHRITIS CARE & RESEARCH
- Effects of Hydroxychloroquine in Patients With Cutaneous Lupus Erythematosus: A Multicenter, Double-Blind, Randomized, Parallel-Group Trial
- (2017) N. Yokogawa et al. Arthritis & Rheumatology
- QTc prolongation as a surrogate for drug-induced arrhythmias: fact or fallacy?
- (2017) Luc M. Hondeghem ACTA CARDIOLOGICA
- New use of an old drug: chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial)
- (2016) Payam Peymani et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Drugs That May Cause or Exacerbate Heart Failure
- (2016) Robert L. Page et al. CIRCULATION
- Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjögren's Syndrome: a Double-Blind Randomized Control Study
- (2016) Chang Ho Yoon et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients
- (2016) Tarun S. Sharma et al. Journal of the American Heart Association
- Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome
- (2014) Jacques-Eric Gottenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Chloroquine use improves dengue-related symptoms
- (2014) Marcos Carvalho Borges et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Effect of Hydroxychloroquine on Insulin Sensitivity and Lipid Parameters in Rheumatoid Arthritis Patients Without Diabetes Mellitus: A Randomized, Blinded Crossover Trial
- (2014) Daniel H. Solomon et al. ARTHRITIS CARE & RESEARCH
- Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized Patients
- (2013) James E. Tisdale et al.
- Safe drug use in long QT syndrome and Brugada syndrome: comparison of website statistics
- (2013) Pieter G. Postema et al. EUROPACE
- Assessing cardiovascular drug safety for clinical decision-making
- (2013) Raymond L. Woosley et al. Nature Reviews Cardiology
- Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases
- (2013) Luis L Rojas-Puentes et al. Radiation Oncology
- Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral Therapy
- (2012) Nicholas I. Paton et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hydroxychloroquine: From Malaria to Autoimmunity
- (2011) Ilan Ben-Zvi et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
- (2010) Vianney Tricou et al. PLoS Neglected Tropical Diseases
- Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies
- (2008) Andreas Lundh et al. BMC Medical Research Methodology
- Inadequate statistical power to detect clinically significant differences in adverse event rates in randomized controlled trials
- (2008) Ruth Tsang et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- On Chikungunya Acute Infection and Chloroquine Treatment
- (2008) Xavier De Lamballerie et al. VECTOR-BORNE AND ZOONOTIC DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search